Diaphragmatic Breathing and Progressive Muscle Relaxation: Behavioral Interventions for Gastrointestinal Rumination

Location:

Rochester, Minn.

Trial status:
Open for Enrollment
Why is this study being done?

Rumination is an upper gastrointestinal (GI) disorder characterized by the frequent regurgitation of recently ingested food. Very little is understood about the nature and treatment of this disorder. The act of regurgitation in rumination involves the opening of the upper esophageal sphincter and the muscular contraction of the abdomins rectus. Behavioral treatment of these symptoms is the clinical intervention of choice; however, only uncontrolled case documentation exists to support its effectiveness. However, an effective behavioral mechanism may be relaxation of the muscles. From a behavioral standpoint, muscular relaxation is incompatible with the necessary muscular contraction for rumination. To date, single case documentation and few designed single case studies have examined the clinical effectiveness of behavioral interventions for GI rumination. In the current study, the investigators seek to examine the effectiveness of two behavioral relaxation interventions for GI rumination through a treatment as usual paradigm (proposed N = 20). Our primary goals are to examine the clinical effectiveness of these interventions in symptom reduction at 1- and 3-month follow-up.

Who is eligible to participate?

Inclusion: 1. At least 18 years of age. 2. Diagnosis of rumination by RomeIII criteria Exclusion Criteria: 1. Active alcohol or substance abuse 2. Presence of a depressive disorder as measured by PHQ-9 score of 10 or above 3. Presence of clinical significant anxiety disorder as measured by GAD-7 score of 10 or above. 4. Severe levels of health focused anxiety as measured by SHAI score of 26 or above. 5. Any medical, neurological, or psychiatric condition that would impair the ability to consent and carry out all study procedures. 6. Any active psychosis or suicidality.

Last updated:
9/30/2013
NCT ID:
NCT01576302
IRB Number:
11-008528